[HTML][HTML] Does tuberculosis threaten our ageing populations?
R Byng-Maddick, M Noursadeghi - BMC infectious diseases, 2016 - Springer
Background The global population is ageing quickly and our understanding of age-related
changes in the immune system suggest that the elderly will have less immunological …
changes in the immune system suggest that the elderly will have less immunological …
[HTML][HTML] Quantitative characterization of the T cell receptor repertoire of naïve and memory subsets using an integrated experimental and computational pipeline which …
T Oakes, JM Heather, K Best, R Byng-Maddick… - Frontiers in …, 2017 - frontiersin.org
The T cell receptor (TCR) repertoire can provide a personalized biomarker for infectious and
non-infectious diseases. We describe a protocol for amplifying, sequencing, and analyzing …
non-infectious diseases. We describe a protocol for amplifying, sequencing, and analyzing …
The impact of biological therapy on regulatory T cells in rheumatoid arthritis
R Byng-Maddick, MR Ehrenstein - Rheumatology, 2015 - academic.oup.com
Regulatory T cells (Treg) are functionally defective in patients with RA. Restoring their function
may not only control inflammation but also restore tolerance in these patients. Biologic …
may not only control inflammation but also restore tolerance in these patients. Biologic …
Recurrent serious infections in patients with rheumatoid arthritis—results from the British Society for Rheumatology Biologics Register
S Subesinghe, AI Rutherford, R Byng-Maddick… - …, 2018 - academic.oup.com
Objectives To establish the rate of recurrent infection in RA patients recruited to the British
Society for Rheumatology Biologics Register – Rheumatoid Arthritis. Secondary objectives …
Society for Rheumatology Biologics Register – Rheumatoid Arthritis. Secondary objectives …
[HTML][HTML] Validation of immune cell modules in multicellular transcriptomic data
Numerous gene signatures, or modules have been described to evaluate the immune cell
composition in transcriptomes of multicellular tissue samples. However, significant diversity in …
composition in transcriptomes of multicellular tissue samples. However, significant diversity in …
Biologic prescribing decisions following serious infection: results from the British Society for Rheumatology Biologics Register—Rheumatoid Arthritis
S Subesinghe, AI Rutherford, R Byng-Maddick… - …, 2018 - academic.oup.com
Objectives To establish whether the decision to stop, continue or switch TNF inhibitor (TNFi)
therapy to a biologic drug with an alternative mode of action following a serious infection (SI) …
therapy to a biologic drug with an alternative mode of action following a serious infection (SI) …
[HTML][HTML] Tumor necrosis factor (TNF) bioactivity at the site of an acute cell-mediated immune response is preserved in rheumatoid arthritis patients responding to anti …
R Byng-Maddick, CT Turner, G Pollara, M Ellis… - Frontiers in …, 2017 - frontiersin.org
The impact of anti-tumor necrosis factor (TNF) therapies on inducible TNF-dependent activity
in humans has never been evaluated in vivo. We aimed to test the hypothesis that patients …
in humans has never been evaluated in vivo. We aimed to test the hypothesis that patients …
Management of persistent inflammatory large joint monoarthritis
R Byng-Maddick, L Jeyalingam, A Keat - Clinical rheumatology, 2012 - Springer
Persistent inflammatory monoarthritis is inflammation of one joint, with symptoms lasting
beyond 3 months. Approximately 50 % of cases are self-limiting; others will transform into oligo- …
beyond 3 months. Approximately 50 % of cases are self-limiting; others will transform into oligo- …
Infections in biological agents used in rheumatic disease
R Byng-Maddick, M Ehrenstein - British Journal of Hospital …, 2012 - magonlinelibrary.com
Immunosuppression and biological therapies are being used exponentially to treat
inflammatory arthritis and connective tissue diseases. This article discusses the potential …
inflammatory arthritis and connective tissue diseases. This article discusses the potential …
[HTML][HTML] Options for taking time out of specialty training
R Byng-Maddick, K Walker-Bone - Clinical Medicine, 2016 - ncbi.nlm.nih.gov
Trainees in higher specialty training programmes may have the option to take time out of
their training programme to enhance or broaden their skills and perhaps develop a …
their training programme to enhance or broaden their skills and perhaps develop a …